Search clinical trials for: ZD6474
Total 78 results
-
University of ChicagoNational Cancer Institute (NCI)CompletedPrecancerous Condition | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous CarcinomaUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
SanofiTerminatedNon-small Cell Lung Cancer (NSCLC)Netherlands
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaCompleted
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent High-Grade Gliomas | Malignant Gliomas | Progressive Low-Grade GliomasUnited States
-
National Cancer Institute (NCI)CompletedRenal Cancer | Von Hippel LindauUnited States
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerItaly, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
Genzyme, a Sanofi CompanyActive, not recruitingThyroid CancerUnited States, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Sweden, Switz...
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, HepatocellularTaiwan
-
National Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyCompletedColorectal CancerGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant NeoplasmUnited States
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerUnited States, France
-
University of Colorado, DenverAstraZenecaCompleted
-
Genzyme, a Sanofi CompanyCompletedBreast Neoplasms | Metastases, NeoplasmSpain, United States
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNon-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States
-
Ronald WeigelAstraZenecaTerminatedInvasive Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedGlioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Anaplastic Mixed OligoastrocytomaUnited States
-
Genzyme, a Sanofi CompanyTerminated
-
Genzyme, a Sanofi CompanyCompletedCarcinoma | Lung Cancer | Non-Small Cell Lung
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
SanofiCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedColorectal CancerUnited States, Korea, Republic of, Spain, United Kingdom, Norway, Argentina
-
University of Wisconsin, MadisonAstraZeneca; University of PittsburghWithdrawnCarcinoma, Non Small Cell Lung
-
Genzyme, a Sanofi CompanyCompletedBiliary Tract Cancer | Gallbladder Cancer | Ampullary Carcinoma | Cancer Of The Extrahepatic Bile DuctItaly
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerItaly
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, South Africa, United Kingdom, Germany, Argentina, Belgium
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's Hospital; Loyola...CompletedSquamous Cell Carcinoma of Head and NeckUnited States
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Italy, South Africa, Spain, Finland, France, Germany, India, Thailand
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNeuroblastomaUnited States
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerUnited States, Australia, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, United Kingdom, Philippines, China, Germany, Norway, Canada, Hong Kong, Argentina, Netherlands, Taiwan, India, Thailand, Indonesia, Denmark
-
Genzyme, a Sanofi CompanyCompletedAdvanced Breast CancerSouth Africa, Sweden, Hungary, Taiwan, Spain
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; AstraZe... and other collaboratorsCompletedTransitional Cell Carcinoma | Bladder CancerUnited States
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non-small Cell Lung CancerVietnam, United States, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, Turkey, Germany, China, Japan, Netherlands, Argentina, Austria, Belgium, Canada, Portugal, Greece, India, Denmark, Malaysia, Indonesia, Thailand, Singapore
-
Genzyme, a Sanofi CompanyCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; AstraZe...CompletedColorectal CancerUnited States
-
Hoosier Cancer Research NetworkAstraZenecaCompletedSmall Cell Lung CancerUnited States
-
PrECOG, LLC.AstraZenecaCompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
Genzyme, a Sanofi CompanyTerminatedMesotheliomaGermany, Switzerland
-
Genzyme, a Sanofi CompanyCompletedAdenocarcinoma | Metastatic | ColorectalUnited Kingdom, Belgium
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Dana-Farber... and other collaboratorsCompletedGlioblastoma Multiforme | GliosarcomaUnited States
-
M.D. Anderson Cancer CenterAstraZenecaTerminated
-
Yonsei UniversityCompleted